Carlyle in talks to acquire two Medtronic units for over $7B, Reuters says

Carlyle Group (CG) has entered into exclusive talks to buy a majority interest in two medical device units from Medtronic (MDT) at a valuation of over $7B, Reuters’ David Carnevali reports, citing people familiar with the matter. Should a deal be reached in the coming weeks, it would mark the culmination of Medtronic’s 12-month review of its patient monitoring and respiratory interventions divisions, that it also weighed spinning off, the author notes.